Pfizer buys rival drugmaker Wyeth for $68 billion
Pharmaceutical giant Pfizer Inc. says it is buying rival drugmaker Wyeth in a US$68 billion cash-and-stock deal that could reshape the drug development industry.
Pfizer Inc. said yesterday it paid US$35-million to about 4,500 doctors and researchers from July through December 2009 for a variety of services, including speaking fees, expert advice and work on clinical trials of its medicines.